Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions
The DOI matches its Crossref record; 129 of the 129 references it cites were found in a registry or an index.
Abstract
More than 80% of patients with type 2 diabetes mellitus develop hypertension, and approx. 20% of patients with hypertension develop diabetes. This combination of cardiovascular risk factors will account for a large proportion of cardiovascular morbidity and mortality. Lowering elevated blood pressure in diabetic hypertensive individuals decreases cardiovascular events. In patients with hypertension and diabetes, the pathophysiology of cardiovascular disease is multifactorial, but recent evidence points toward the presence of an important component dependent on a low-grade inflammatory process. Angiotensin II may be to a large degree responsible for triggering vascular inflammation by inducing oxidative stress, resulting in up-regulation of pro-inflammatory transcription factors such as NF-κB (nuclear factor κB). These, in turn, regulate the generation of inflammatory mediators that lead to endothelial dysfunction and vascular injury. Inflammatory markers (e.g. C-reactive protein, chemokines and adhesion molecules) are increased in patients with hypertension and metabolic disorders, and predict the development of cardiovascular disease. Lifestyle modification and pharmacological approaches (such as drugs that target the renin–angiotensin system) may reduce blood pressure and inflammation in patients with hypertension and metabolic disorders, which will reduce cardiovascular risk, development of diabetes and cardiovascular morbidity and mortality.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ACE-I/ARBs are typically prescribed to decrease blood pressure and sympathetic activity (Savoia and Schiffrin, 2007).”
From Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond (2017) · cites this paper as Savoia and Schiffrin, 2007
In the citing paper
“there is considerable evidence that its underlying cause is inflammatory in nature [678-686]”
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections
King, H., Aubert, R. E., & Herman, W. H. (1998) · Diabetes Care · doi:10.2337/diacare.21.9.1414 · Cited by 6,311
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 6,090
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Stamler, J., Vaccaro, O., Neaton, J. D., Wentworth, D., & The Multiple Risk Factor Intervention Trial Research Group (1993) · Diabetes Care · doi:10.2337/diacare.16.2.434 · Cited by 4,063
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899
Research works printed but not linked: 1
- Schöbeck, 2004, Inflammation, immunity, and HMG-CoA reductase inhibitors statins as anti-inflammatory agents?, Circulation, 109, II18
Cited by
Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond
Michopoulos, V., Powers, A., Gillespie, C. F., Ressler, K. J., & Jovanovic, T. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.146 · Cited by 786
“…and blockers (ARBs) in the treatment of PTSD, as these classes of pharmacological agents are effective in managing cardio-metabolic disease that is highly co-morbid with PTSD. ACE-I/ARBs are typically prescribed to decrease blood pressure and sympathetic activity (Savoia and Schiffrin, 2007).”
BackgroundDiabetes and Hypertension: Is There a Common Metabolic Pathway?
Cheung, B. M. Y., & Li, C. (2012) · Current Atherosclerosis Reports · doi:10.1007/s11883-012-0227-2 · Cited by 576
“stress [49].”
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
“inflammatory in nature [678-686], is related to the”
BackgroundImpaired Tissue Perfusion: A Pathology Common to Hypertension, Obesity, and Diabetes Mellitus
Levy, B. I., Schiffrin, E. L., Mourad, J.-J., Agostini, D., Vicaut, E., Safar, M. E., & Struijker-Boudier, H. A. J. (2008) · Circulation · doi:10.1161/circulationaha.107.763730 · Cited by 470
Self-citationEndothelial Dysfunction in Hypertension: Current Concepts and Clinical Implications
Gallo, G., Volpe, M., & Savoia, C. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.798958 · Cited by 446
“Essential hypertension is characterized by functional and structural alterations in resistance arteries which lead to increased peripheral vascular resistance (7).”
BackgroundSelf-citationHeart failure with preserved ejection fraction: from mechanisms to therapies
Lam, C. S. P., Voors, A. A., de Boer, R. A., Solomon, S. D., & van Veldhuisen, D. J. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy301 · Cited by 355
Obesity and diabetes: An update
Verma, S., & Hussain, M. E. (2017) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2016.06.017 · Cited by 318
Salim, S., Chugh, G., & Asghar, M. (2012) · Advances in Protein Chemistry and Structural Biology · doi:10.1016/b978-0-12-398314-5.00001-5 · Cited by 310
“…cardiovascular and metabolic disorders where inflammation is a major pathogenic factor (Barra, Vitagliano, Cuomo, Vitagliano, & Gaeta, 2009; Savoia & Schiffrin, 2007); however, an increasing body of evidence now suggests their extended antianxiety and antidepressant properties (Gard,…”
Pyroptosis and its relationship to atherosclerosis
Xu, Y.-J., Zheng, L., Hu, Y.-W., & Wang, Q. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.11.005 · Cited by 321
Vascular Remodeling in Hypertension: Mechanisms and Treatment
Schiffrin, E. L. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.187021 · Cited by 276
Self-citationSaavedra, J. M., Sánchez-Lemus, E., & Benicky, J. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.10.001 · Cited by 260
“…Angiotensin II is a well-known pro-inflammatory factor in peripheral tissues, sharing signal transduction pathways with other inflammatory stimuli (Savoia and Schiffrin, 2007) and the anti-inflammatory effects of ARBs in hypertension and diabetes are well established (Savoia and Schiffrin, 2007).”
BackgroundAngiotensin II AT1 Receptor Blockade Ameliorates Brain Inflammation
Benicky, J., Sánchez-Lemus, E., Honda, M., Pang, T., Orecna, M., Wang, J., Leng, Y., Chuang, D.-M., & Saavedra, J. M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.225 · Cited by 254
“For this reason ARBs, compounds with excellent safety margins, are commonly used not only to regulate blood pressure, but also for their capacity to protect end organs, thus decreasing heart failure and renal damage (Savoia and Schiffrin, 2007).”
InfluentialPsoriasis and the Risk of Diabetes and Hypertension: A Prospective Study of US Female Nurses
Qureshi, A. A., Choi, H. K., Setty, A. R., & Curhan, G. C. (2009) · Archives of Dermatology · doi:10.1001/archdermatol.2009.48 · Cited by 250
“More than 80% of individuals with diabetes develop hypertension, and approximately 20% of individuals with hypertension develop diabetes.(16) In patients with hypertensionanddiabetes, thepathogenesis of cardiovascular disease is multifactorial, but recent evidencepoints toward thepresenceofa low-grade inflammatoryproc…”
BackgroundRole of nuclear factor κB in cardiovascular health and disease
van der Heiden, K., Cuhlmann, S., Luong, L. A., Zakkar, M., & Evans, P. C. (2010) · Clinical Science · doi:10.1042/cs20090557 · Cited by 234
INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES
Baru, P. C. R. (2014) · ADVANCED SCIENCES INDEX · Cited by 236
Inflammation, Metabolic Syndrome, Erectile Dysfunction, and Coronary Artery Disease: Common Links
Vlachopoulos, C., Rokkas, K., Ioakeimidis, N., & Stefanadis, C. (2007) · European Urology · doi:10.1016/j.eururo.2007.08.004 · Cited by 230
“Furthermore, although a recent retrospective study did not find any association between the level of inflammatory activation and self-reported ED [32], we recently showed that sexual performance assessed by the International Index of Erectile Function 5 (IIEF-5) score correlates inversely with the circulating levels o…”
BackgroundInfluentialAngiotensin II AT1 receptor blockers as treatments for inflammatory brain disorders
Saavedra, J. M. (2012) · Clinical Science · doi:10.1042/cs20120078 · Cited by 217
“In addition, low-grade chronic inflammation with an increased expression of monocyte-derived inflammatory factors is an established component of peripheral vascular inflammatory disease in hypertension [6].”
InfluentialThe renin–angiotensin system and diabetes: An update
Silva, A. C. S. E. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s1905 · Cited by 216
Angiotensin II and the development of insulin resistance: Implications for diabetes
Olivares-Reyes, J. A., Arellano-Plancarte, A., & Castillo-Hernandez, J. R. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.12.011 · Cited by 202
Protecting against vascular disease in brain
Faraci, F. M. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01310.2010 · Cited by 196
“Components of the inflammatory response are activated within the vasculature during aging and in many diseases including atherosclerosis, hypertension, and diabetes (57, 72, 180, 243, 257).”
BackgroundGlezeva, N., & Baugh, J. A. (2014) · Heart Failure Reviews · doi:10.1007/s10741-013-9405-8 · Cited by 187
“In addition to the role of inflammation in late ventricular remodelling and HF stabilization, early vascular inflammation has been shown to be the most common precursor of comorbidities prevalent in HFPEF such as HTN, atherosclerosis, and CAD [29], and asymptomatic individuals with even slight evidence of low-grade va…”
BackgroundThe angiotensin II type 2 receptor in cardiovascular disease
Lemarié, C. A., & Schiffrin, E. L. (2010) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320309347785 · Cited by 179
“The presence of an inflammatory response in the arterial wall has been described in vascular disease, including atherosclerosis and hypertension.(5,65,67) Endothelial dysfunction is characterised by increasing adhesiveness of circulating monocytes to the endothelium and expression of adhesion molecules as observed in…”
Self-citationImmune mechanisms in hypertension and vascular injury
Schiffrin, E. L. (2014) · Clinical Science · doi:10.1042/cs20130407 · Cited by 182
Self-citationArsenic Exposure and Cardiovascular Disorders: An Overview
Balakumar, P., & Kaur, J. (2009) · Cardiovascular Toxicology · doi:10.1007/s12012-009-9050-6 · Cited by 175
“a marker of atherosclerotic risk, is often associated with the pathogenesis of various chronic disorders such as atherosclerosis [24], hypertension [25], heart failure [17] and”
BackgroundSiam, N. H., Snigdha, N. N., Tabasumma, N., & Parvin, I. (2024) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2512436 · Cited by 213
“The oxidation of weak cell membrane unsaturated lipids may stimulate diverse signal transduction pathways to drive various adverse events associated with atherosclerosis pathophysiology [74].”
Endogenous Interleukin-10 Inhibits Angiotensin II–Induced Vascular Dysfunction
Didion, S. P., Kinzenbaw, D. A., Schrader, L. I., Chu, Y., & Faraci, F. M. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.137158 · Cited by 162
Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies
Spinetti, G., Kraenkel, N., Emanueli, C., & Madeddu, P. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn039 · Cited by 162
“Diabetes-associated EC dysfunction facilitates vascular inflammation via GF and cytokine secretion, and adhesion molecules expression.(78) Increased leukocyte affinity to EC has been linked to the pathogenesis of diabetic microangiopathy and atherogenesis.”
Hypertension and COVID-19: Current Evidence and Perspectives
Gallo, G., Calvez, V., & Savoia, C. (2022) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-022-00506-9 · Cited by 175
Self-citationPosttraumatic stress disorder: A metabolic disorder in disguise?
Michopoulos, V., Vester, A., & Neigh, G. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.05.038 · Cited by 152
“These pharmacological agents not only attenuate blood pressure (Savoia and Schiffrin, 2007), but also reduce neuroinflammation (Benicky et al., 2011; Welty et al., 2015), as angiotensin-II acts as a pro-inflammatory signal to induce the release of CRP (Peng et al., 2007; Zhao et al., 2013) and IL-6…”
Miguel‐Carrasco, J. L., Zambrano, S. S., Blanca, A. J., Mate, A., & Vázquez, C. M. (2010) · Journal of Inflammation · doi:10.1186/1476-9255-7-21 · Cited by 150
“expression of pro-inflammatory cytokines, such as IL-6, through an inactivation of NF-κB [55].”
BackgroundMathew, M., Tay, E., & Cusi, K. J. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-9 · Cited by 157
“Atherosclerosis in obesity, metabolic syndrome and T2DM is initiated by damage/activation of the endothelium [2,4,8].”
BackgroundMuhammad, H. F. L., van Baak, M. A., Mariman, E. C. M., Sulistyoningrum, D. C., Huriyati, E., Lee, Y. Y., & Muda, W. A. M. W. (2019) · Nutrients · doi:10.3390/nu11010148 · Cited by 148
“It was previously suggested that inflammation plays an important role in the disturbance of blood pressure and lipid profile [3,16,17].”
Background20-HETE and Blood Pressure Regulation: Clinical Implications
Wu, C., Gupta, T., Garcia, V. G., Ding, Y., & Schwartzman, M. L. (2013) · Cardiology in Review · doi:10.1097/crd.0b013e3182961659 · Cited by 149
The renin–angiotensin system: a possible new target for depression
Vian, J., Pereira, C., Chavarria, V., Köhler, C., Stubbs, B., Quevedo, J., Kim, S.-W., Carvalho, A. F., Berk, M., & Fernandes, B. S. (2017) · BMC Medicine · doi:10.1186/s12916-017-0916-3 · Cited by 134
“Overstimulation of AT1Rs can lead to endothelial dysfunction [67] and neuronal injury and vulnerability caused by cerebrovascular remodelling [68–72].”
BackgroundRodrigues‐Díez, R., González‐Guerrero, C., Ocaña-Salceda, C., Rodrigues-Díez, R. R., Egido, J., Ortíz, A., Ruiz‐Ortega, M., & Ramos, A. M. (2016) · Scientific Reports · doi:10.1038/srep27915 · Cited by 131
Arachidonic acid in health and disease with focus on hypertension and diabetes mellitus: A review
Das, U. N. (2018) · Journal of Advanced Research · doi:10.1016/j.jare.2018.01.002 · Cited by 138
Pyroptosis in the Initiation and Progression of Atherosclerosis
Qian, Z., Zhao, Y., Wan, C., Deng, Y., Zhuang, Y., Xu, Y., Zhu, Y., Lu, S., & Bao, Z. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.652963 · Cited by 138
“As inflammation in subendothelial worsen, the incompletely differentiated SMCs proliferate and migrate to the endothelial, accelerate the progression of atherosclerosis (Choy et al., 2001; Savoia and Schiffrin, 2007).”
BackgroundAnti-Inflammatory Effects of Angiotensin Receptor Blockers in the Brain and the Periphery
Benický, J., Sánchez-Lemus, E., Pavel, J., & Saavedra, J. M. (2009) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9368-4 · Cited by 137
“Of prime importance is the proinflammatory effect of Ang II in the peripheral vasculature in hypertension (Cheng et al. 2005; Sanz-Rosa et al. 2005; Suzuki et al. 2003), because inflammation is now recognized as a major factor in the development and maintenance of this disease ( Savoia and Schiffrin 2006, 2007 ).”
BackgroundVillapol, S., Yaszemski, A. K., Logan, T. T., Sánchez-Lemus, E., Saavedra, J. M., & Symes, A. J. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.152 · Cited by 125
“However, excessive AT1R stimulation leads to inflammation, increasing oxidative stress, and endothelial dysfunction both in the periphery (Savoia and Schiffrin, 2007) and in the brain (Ozacmak et al, 2007).”
BackgroundMicrocirculation and oxidative stress
Crimi, E., Ignarro, L. J., & Claudio Napoli, A. (2007) · Free Radical Research · doi:10.1080/10715760701732830 · Cited by 136
de Batista, P. R., Palacios, R., Martín, Á., Hernanz, R., Médici, C. T., Silva, M. A. S. C., Rossi, E. M., Aguado, A., Vassallo, D. V., Salaíces, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104020 · Cited by 128
“Increased activation of the renin-angiotensin system (RAS) seems to be associated with the inflammatory state observed in hypertension, as well as with its associated vascular alterations [1,5,11,12].”
BackgroundInfluentialInflammation and oxidative stress markers in diabetes and hypertension
Pouvreau, C., Dayre, A., Butkowski, E., de Jong, B., & Jelinek, H. F. (2018) · Journal of Inflammation Research · doi:10.2147/jir.s148911 · Cited by 126
“42 Changes in individual oxidative stress and inflammatory biomarkers in HTN and T2DM have been previously studied, 8,43–44 but how or whether oxidative stress and inflammatory biomarkers act together in HTN progression with and without presence of T2DM has not been fully elucidated.”
The Immune System: Role in Hypertension
Schiffrin, E. L. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.06.009 · Cited by 115
Self-citationT lymphocytes: a role in hypertension?
Schiffrin, E. L. (2010) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3283360a2e · Cited by 110
Self-citationFallah, A. A., Sarmast, E., Fatehi, P., & Jafari, T. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.110922 · Cited by 115
Wang, J., Pang, T., Hafko, R., Benický, J., Sánchez-Lemus, E., & Saavedra, J. M. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.11.022 · Cited by 118
“For these reasons sartans are commonly used for the treatment of cardiovascular and renal disease and diabetes (Chrysant et al., 2010; Konstam et al., 2009; Savoia and Schiffrin, 2007).”
Disruption of SM22 Promotes Inflammation After Artery Injury via Nuclear Factor κB Activation
Shen, J., Yang, M., Ju, D., Jiang, H., Zheng, J.-P., Xu, Z., & Li, L. (2010) · Circulation Research · doi:10.1161/circresaha.109.213900 · Cited by 107
Relation of iron and red meat intake to blood pressure: cross sectional epidemiological study
Tzoulaki, I., Brown, I. J., Chan, Q. M., Horn, L. V., Ueshima, H., Zhao, L., Stamler, J., & Elliott, P. (2008) · BMJ · doi:10.1136/bmj.a258 · Cited by 115
“The relation between iron and blood pressure is largely unknown. Iron is a redox active transition metal that might contribute to the production of reactive oxygen species, oxidative stress, and inflammation—all possibly adversely related to blood pressure levels.”
BackgroundAngiotensin Receptor Blockers: Pharmacology, Efficacy, and Safety
Taylor, A. A., Siragy, H. M., & Nesbitt, S. D. (2011) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2011.00518.x · Cited by 114
“Circulating Biochemical Markers of Vascular Inflammation Angiotensin II has been identified in studies of tissues and experimental animals as a proinflammatory molecule that stimulates the formation of reactive oxygen species, resulting in the upregulation of inflammatory mediators such as the transcription factor NF-…”
BackgroundHypertension: a systemic key to understanding local keloid severity
Arima, J., Huang, C., ROSNER, B. A., Akaishi, S., & Ogawa, R. (2015) · Wound Repair and Regeneration · doi:10.1111/wrr.12277 · Cited by 105
Lukic, L., Lalic, N., Rajkovic, N., Jotic, A., Lalic, K., Milicic, T., Seferovic, J., Macesic, M., & Gajovic, J. (2014) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph110403586 · Cited by 94
“It has been shown that more than 80% of patients with type 2 diabetes (T2D) will become hypertensive and it has been postulated that both T2D and hypertension represent potent risk factors for the development of different forms of ischemic cardiovascular disorders [1].”
BackgroundThe role of 20-HETE in cardiovascular diseases and its risk factors
Waldman, M., Peterson, S. J., Arad, M., & Hochhauser, E. (2016) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2016.05.007 · Cited by 98
Autophagy regulates inflammation following oxidative injury in diabetes
Wang, Y., Li, Y.-B., Yin, J.-J., Wang, Y., Zhu, L.-B., Xie, G.-Y., & Pan, S.-H. (2013) · Autophagy · doi:10.4161/auto.23628 · Cited by 92
“AGTR2 (angiotensin II receptor, type 2) is to a large degree responsible for triggering inflammation by inducing oxidative stress in obese states, which supports the relationship between inflammation and obesity in humans.(25) AGTR2 also downregulates pro-inflammatory transcription factors such as NFKB, resulting in t…”
BackgroundA Nephrologist Perspective on Obesity: From Kidney Injury to Clinical Management
García-Carro, C., Vergara, A., Bermejo, S., Azancot, M. A., Sellarés, J., & Soler, M. J. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.655871 · Cited by 101
Saavedra, J. M. (2011) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9754-6 · Cited by 100
“…limited to reduction of vasoconstriction, but also include a significant decrease in vascular and end-organ inflammation, the result of excessive AT1 receptor activation and a major participant in the pathogenesis of hypertension and diabetes (Savoia and Schiffrin 2007; Marchesi et al. 2008) (Fig.”
BackgroundInfluentialRole of microRNAs in endothelial inflammation and senescence
Qin, B., Yang, H., & Xiao, B. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-1241-0 · Cited by 91
Is targeting eNOS a key mechanistic insight of cardiovascular defensive potentials of statins?
Balakumar, P., Kathuria, S., Taneja, G., Kalra, S., & Mahadevan, N. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.09.014 · Cited by 90
Emerging Role for TNF-α in Erectile Dysfunction
Carneiro, F. S., Webb, R. C., & Tostes, R. C. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01762.x · Cited by 97
“Results—TNF-α has been shown to play an important role in CVD, mainly due to its direct effects on the vasculature.”
BackgroundInfluentialYang, X., Yin, Y., & Wang, H. (2008) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2008.11.003 · Cited by 96
“EC dysfunction is characterized by impaired vasomotor response (reduced vasodilation and increased EC-dependent contraction), cell proliferation, platelet adhesion/aggregation, vascular permeability and leukocyte-endothelial interactions that participate in vascular inflammation [21].”
BackgroundMitochondrial function in vascular endothelial cell in diabetes
Pangare, M., & Makino, A. (2012) · Journal of Smooth Muscle Research · doi:10.1540/jsmr.48.1 · Cited by 84
“…permeability (Zhang et al., 2003; Spinetti et al., 2008) and surface adhesion molecules (Baumgartner-Parzer et al., 1995; Zou et al., 2002; Savoia and Schiffrin, 2007), and 3) endothelial apoptosis is increased, which is a main cause of the blood-retina barrier breakdown (Kern, 2007;…”
Setty, Y. B. N., & Betal, S. G. (2007) · Blood · doi:10.1182/blood-2007-07-099465 · Cited by 89
Hyperresistinemia Is Associated With Coexistence of Hypertension and Type 2 Diabetes
Takata, Y., Osawa, H., Kurata, M., Kurokawa, M., Yamauchi, J., Ochi, M., Nishida, W., Okura, T., Higaki, J., & Makino, H. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.103077 · Cited by 86
Commercially Available Angiotensin II At2 Receptor Antibodies Are Nonspecific
Hafko, R., Villapol, S., Nostramo, R., Symes, A. J., Sabban, E. L., Inagami, T., & Saavedra, J. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069234 · Cited by 87
“AT1 receptor overactivity promotes peripheral vascular and tissue inflammation [6] and it is associated with essential hypertension, metabolic dysfunction, renal disease, brain inflammation and neuronal injury [4–7].”
BackgroundImmune System and Microvascular Remodeling in Humans
Rizzoni, D., Ciuceis, C. D., Szczepaniak, P., Paradis, P., Schiffrin, E. L., & Guzik, T. J. (2022) · Hypertension · doi:10.1161/hypertensionaha.121.17955 · Cited by 88
Self-citationImpact of coffee components on inflammatory markers: A review
Frost-Meyer, N. J., & Logomarsino, J. V. (2012) · Journal of Functional Foods · doi:10.1016/j.jff.2012.05.010 · Cited by 102
Essential Hypertension: Is There a Role for Inflammatory Mechanisms?
Androulakis, E. S., Tousoulis, D., Παπαγεωργίου, Ν., Tsioufis, C. P., Kallikazaros, I. E., & Stefanadis, C. (2009) · Cardiology in Review · doi:10.1097/crd.0b013e3181b18e03 · Cited by 103
Is nicotine a key player or spectator in the induction and progression of cardiovascular disorders?
Balakumar, P., & Kaur, J. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.06.005 · Cited by 91
Blueberry Metabolites Attenuate Lipotoxicity‐Induced Endothelial Dysfunction
Bharat, D., Cavalcanti, R. R. M., Petersen, C., Begaye, N., Cutler, B. R., Costa, M. M. A., Ramos, R. K. L. G., Ferreira, M. R., Li, Y., Bharath, L. P., et al. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700601 · Cited by 84
Antihypertensive Role of Polyphenols
Rodrigo, R., Gil, D., Miranda-Merchak, A., & Kalantzidis, G. (2012) · Advances in clinical chemistry · doi:10.1016/b978-0-12-394383-5.00014-x · Cited by 93
ADAM17-Mediated Shedding of Inflammatory Cytokines in Hypertension
de Queiroz, T. M., Lakkappa, N., & Lazartigues, E. D. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01154 · Cited by 88
“Ang-II is reported to activate circulating cells and their adhesion to the activated endothelium, followed by transmigration through synthesis of adhesion molecules, chemokines and cytokines, resulting in renal and vascular hypertension (Li and Chen, 2005; Ruiz-Ortega et al., 2006; Savoia and Schiffrin, 2007).”
BackgroundThe role of 20-HETE in androgen-mediated hypertension
Wu, C., & Schwartzman, M. L. (2011) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2011.06.006 · Cited by 86
Effects and Mechanisms of Tea Regulating Blood Pressure: Evidences and Promises
Li, D., Wang, R., Huang, J., Cai, Q., Yang, C. S., Wan, X., & Xie, Z. (2019) · Nutrients · doi:10.3390/nu11051115 · Cited by 87
“Hypertension may be caused by vascular inflammation and remodeling [76,77].”
BackgroundMayyas, F., Alzoubi, K. H., & Wagoner, D. R. V. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.08.022 · Cited by 82
“Aldosterone infusion in rats resulted in impaired endothelial relaxation, and increased oxidative stress in the vessel [36,38].”
BackgroundDe Ciuceis, C., Porteri, E., Rizzoni, D., Corbellini, C., La Boria, E., Boari, G. E. M., Pilu, A., Mittempergher, F., Di Betta, E., Casella, C., et al. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.171082 · Cited by 76
End-organ dysfunction and cardiovascular outcomes: the role of the microcirculation
Lockhart, C., Hamilton, P., Quinn, C. E., & McVeigh, G. E. (2009) · Clinical Science · doi:10.1042/cs20080069 · Cited by 80
Pathogenesis and pathophysiology of accelerated atherosclerosis in the diabetic heart
D’Souza, A., Hussain, M., Howarth, F. C., Woods, N. M., Bidasee, K. R., & Singh, J. (2009) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-009-0148-8 · Cited by 86
“Serum concentrations of VCAM-1 and ICAM-1 have been found to be elevated in subjects with type 2 DM and CVD [126] and circulating concentrations of ICAM have been correlated with risk of CHD [92].”
BackgroundInfluentialKlotho Prevents Translocation of NFκB
Buendía, P., Ramírez, R., Aljama, P., & Carracedo, J. (2016) · Vitamins and hormones · doi:10.1016/bs.vh.2016.02.005 · Cited by 83
Microvascular structure as a prognostically relevant endpoint
Agabiti‐Rosei, E., & Rizzoni, D. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001259 · Cited by 70
“process that might have an important role to play as a mechanism in the progression of cardiovascular disease [33,34].”
BackgroundHe, C., Li, H., Viollet, B., Zou, M., & Xie, Z. (2015) · Diabetes · doi:10.2337/db15-0107 · Cited by 77
“AngII is a proinflammatory peptide (40) and contributes to diabetesinduced vascular inflammation (41).”
BackgroundWang, S., Zhan, J., Lin, X., Wang, Y., Wang, Y., & Liu, Y. (2020) · Cell Biochemistry and Function · doi:10.1002/cbf.3543 · Cited by 67
“Vascular complications account for a large proportion of morbidity and mortality in diabetic patients.(27) Vascular aging has been identified as an important risk factor in diabetic vascular complications.”
BackgroundSima, C., Rhourida, K., Dyke, T. E. V., & Gyurko, R. (2010) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2010.01295.x · Cited by 65
Balakumar, P., Kaur, T., & Singh, M. (2007) · Toxicology · doi:10.1016/j.tox.2007.12.011 · Cited by 71
Pang, T., Benický, J., Wang, J., Orečná, M., Sánchez-Lemus, E., & Saavedra, J. M. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834dde5f · Cited by 66
Angiotensin type 2 receptor in hypertensive cardiovascular disease
Savoia, C., D’Agostino, M., Lauri, F. M., & Volpe, M. (2011) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3283437fcd · Cited by 66
Self-citationNew aspects of adipogenesis: Radicals and oxidative stress
Gummersbach, C., Hemmrich, K., Kröncke, K., Suschek, C. V., Fehsel, K., & Pallua, N. (2009) · Differentiation · doi:10.1016/j.diff.2008.09.009 · Cited by 59
“Also, impaired glucose utilization and lactate production as a result of oxidative stress promote diabetes mellitus and vascular diseases (Savoia and Schiffrin, 2007).”
BackgroundGlycated Hemoglobin and Risk of Hypertension in the Atherosclerosis Risk in Communities Study
Bower, J. K., Appel, L. J., Matsushita, K., Young, J. H., Alonso, Á., Brancati, F. L., & Selvin, E. (2012) · Diabetes Care · doi:10.2337/dc11-2248 · Cited by 66
“In addition, inflammatory processes have been implicated in both the development of hyperglycemia and hypertension (32).”
BackgroundAldosterone activates endothelial exocytosis
Jeong, Y., Chaupin, D. F., Matsushita, K., Yamakuchi, M., Cameron, S. J., Morrell, C. N., & Lowenstein, C. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804037106 · Cited by 59
Cardiovascular disease and COVID-19: les liaisons dangereuses
Barison, A., Aimo, A., Castiglione, V., Arzilli, C., Lupón, J., Codina, P., Santiago‐Vacas, E., Cediel, G., Emdin, M., & Bayés‐Genís, A. (2020) · European Journal of Preventive Cardiology · doi:10.1177/2047487320924501 · Cited by 61
“• Cardiovascular risk factors are associated with systemic inflammatory activation, 50 which combines with the virus-induced immune response and increases the global inflammatory burden.”
BackgroundVirdis, A., Savoia, C., Grassi, G. M., Lembo, G., Vecchione, C., Seravalle, G., Taddei, S., Volpe, M., Rosei, E. A., & Rizzoni, D. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000322 · Cited by 58
Self-citationState of the Art Review: Vascular Remodeling in Hypertension
Rizzoni, D., Rosei, C. A., & Ciuceis, C. D. (2022) · American Journal of Hypertension · doi:10.1093/ajh/hpac093 · Cited by 60
Willette, R. N., Eybye, M. E., Olzinski, A. R., Behm, D. J., Aiyar, N. V., Maniscalco, K., Bentley, R. G., Coatney, R. W., Zhao, S., Westfall, T. D., et al. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.154443 · Cited by 55
“, coronary artery disease, heart failure, hypertension, and other components of the metabolic syndrome (Grundy, 2003; Berg and Scherer, 2005; De Tena et al., 2005; Forrester and Libby, 2007; Savoia and Schiffrin, 2007).”
Ribonucleic Acid Interference Knockdown of Interleukin 6 Attenuates Cold-Induced Hypertension
Crosswhite, P. L., & Sun, Z. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.146902 · Cited by 56
Elevated Serum Level of Interleukin 17 in a Population With Prehypertension
Yao, W., Sun, Y., Wang, X., & Niu, K. (2015) · Journal of Clinical Hypertension · doi:10.1111/jch.12612 · Cited by 53
“Immune responses play a key role in the vascular remodeling that leads to blood pressure (BP) elevation.(2,3) Early studies suggested that the thymus is important in experimental hypertension in rodents.”
BackgroundLima, V. V., Rigsby, C. S., Hardy, D. M., Webb, R. C., & Tostes, R. C. (2009) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2009.09.004 · Cited by 62
“Recent evidence shows that increased O-GlcNAcylation also interferes with many aspects of the inflammatory process, which represents another important feature of the hypertensive disease.(124) For example, in rat mesangial cells increased flux through the HBP leads to nuclear factor-kB promoter activation and increase…”
BackgroundPuchau, B., Zulet, M. Á., de Echávarri, A. G., Navarro-Blasco, Í., & Martínez, J. A. (2008) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2008.48 · Cited by 56
“Smoking status, physical activity and alcohol intake as well as pharmacological treatments have been reported as possible factors related to inflammation and blood pressure levels in subjects with hypertension and metabolic disorders (Savoia and Schiffrin, 2007).”
BackgroundCiuceis, C. D., Salvetti, M., Rossini, C., Muiesan, M. L., Paini, A., Duse, S., Boria, E. L., Semeraro, F., Cancarini, A., Rosei, C. A., et al. (2013) · Journal of Hypertension · doi:10.1097/hjh.0000000000000067 · Cited by 51
“Moreover, dihydropyridine calcium channel blockers [17,18,22,23,38] and RAS blockers [19] have favourable effects on oxidative stress and inflammation, thus”
BackgroundObesity genetics and cardiometabolic health: Potential for risk prediction
Sanghera, D. K., Bejar, C., Sharma, S., Gupta, R., & Blackett, P. R. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13641 · Cited by 55
“It also has a direct effect on increasing insulin resistance independent of alterations in blood flow and interstitial insulin concentration,(55) but angiotensin II is equally responsible for influencing the arterial wall through vascular inflammation.(56,57) The insulin resistance is reversible by selective inhibitor…”
BackgroundPiqueras, L., & Sanz, M. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.02.002 · Cited by 54
Eid, A. H., Abdelkader, N. F., El‐Raouf, O. M. A., Fawzy, H. M., & El-Denshary, E.-E.-D. S. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0833-6 · Cited by 50
“Furthermore, oxidative mediators are known to trigger inflammatory cascades by upregulating transcription factors, including nuclear factor-kappa B (NF-jB) (Savoia and Schiffrin 2007), which sequentially enhances the & Noha F.”
BackgroundIntegrating diet and inflammation to calculate cardiovascular risk
Gambardella, J., & Santulli, G. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.08.041 · Cited by 52
“Equally important, some covariates such as hypertension and diabetes are labeled as potential confounders; however, by correcting for these factors, the investigators can partially correct for the effect of DII itself, since these parameters have been independently linked to inflammation [23].”
Metadata
- Authors
- Savoia, C., & Schiffrin, E. L.
- Affiliations
- Jewish General Hospital (CA)
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2007-03-01
- Volume
- 112
- Issue
- 7
- Pages
- 375-384
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W1975582897
- Cited by
- 326
- References
- 129
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 8 · 2023: 7 · 2022: 13 · 2021: 10 · 2020: 21 · 2019: 14 · 2018: 15 · 2017: 20 · 2016: 18 · 2015: 24 · 2014: 21 · 2013: 23 · 2012: 21
- FWCI
- 2.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Science (publishedVersion)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Keywords
- vascular inflammation, hypertension, type 2 diabetes, angiotensin II, oxidative stress, NF-κB, endothelial dysfunction, cardiovascular risk, C-reactive protein, chemokines, adhesion molecules, renin-angiotensin system, blood pressure reduction, lifestyle modification
- MeSH terms
- Aldosterone, Angiotensin II, Diabetes Mellitus, Type 2, Humans, Hypertension, Renin-Angiotensin System, Vasculitis, Cell Adhesion Molecules, Cytokines, NF-kappa B, Disease Progression, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.